| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |